Peregrine Capital Management LLC acquired a new position in shares of Glaukos Corporation (NYSE:GKOS) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 329,024 shares of the medical instruments supplier’s stock, valued at approximately $13,645,000. Peregrine Capital Management LLC owned approximately 0.96% of Glaukos Corporation as of its most recent filing with the SEC.
Several other institutional investors have also recently added to or reduced their stakes in GKOS. American Century Companies Inc. raised its position in Glaukos Corporation by 2.6% in the first quarter. American Century Companies Inc. now owns 135,082 shares of the medical instruments supplier’s stock worth $6,930,000 after buying an additional 3,458 shares during the period. Great West Life Assurance Co. Can bought a new stake in shares of Glaukos Corporation during the first quarter worth $102,000. Tocqueville Asset Management L.P. bought a new stake in shares of Glaukos Corporation during the first quarter worth $487,000. Wells Fargo & Company MN increased its stake in shares of Glaukos Corporation by 73.2% in the first quarter. Wells Fargo & Company MN now owns 1,156,562 shares of the medical instruments supplier’s stock worth $59,332,000 after buying an additional 488,730 shares in the last quarter. Finally, DUPONT CAPITAL MANAGEMENT Corp bought a new stake in shares of Glaukos Corporation during the first quarter worth $776,000. Institutional investors own 88.92% of the company’s stock.
Glaukos Corporation (GKOS) traded down 0.84% on Friday, hitting $40.33. 365,311 shares of the company’s stock traded hands. The stock has a market cap of $1.38 billion, a P/E ratio of 366.64 and a beta of 1.33. Glaukos Corporation has a 12 month low of $28.26 and a 12 month high of $52.49. The stock has a 50 day moving average price of $41.11 and a 200-day moving average price of $43.09.
ILLEGAL ACTIVITY NOTICE: This article was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://stocknewstimes.com/2017/07/22/peregrine-capital-management-llc-acquires-shares-of-329024-glaukos-corporation-nysegkos.html.
A number of equities research analysts recently weighed in on GKOS shares. Zacks Investment Research downgraded shares of Glaukos Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, May 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $54.00 target price on shares of Glaukos Corporation in a research note on Thursday, May 4th. TheStreet downgraded shares of Glaukos Corporation from a “c” rating to a “d+” rating in a research note on Wednesday, May 3rd. Stephens raised shares of Glaukos Corporation from an “equal weight” rating to an “overweight” rating in a research note on Monday, May 8th. Finally, BMO Capital Markets reaffirmed a “buy” rating and issued a $54.00 target price on shares of Glaukos Corporation in a research note on Tuesday, April 11th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $48.67.
About Glaukos Corporation
Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm’s canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream.
Want to see what other hedge funds are holding GKOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Glaukos Corporation (NYSE:GKOS).
Receive News & Ratings for Glaukos Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glaukos Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
